NurExone Biologic Inc. research brief
CIK 1995074
Generated Nov. 19, 2026, 12:01 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: TECHNION CITY, HAIFA Israel. Reported legal jurisdiction: ONTARIO, CANADA. These do not establish investor residence or where funds were deployed.
- Aug. 21, 2026 · D · 0001995074-26-000004 · Source evidence
Reported offering amount: 450456 USD. Reported amount sold: 450456 USD.
- July 2, 2026 · D · 0001995074-26-000003 · Source evidence
Reported offering amount: 441779 USD. Reported amount sold: 441779 USD.
- March 18, 2026 · D · 0001995074-26-000002 · Source evidence
Reported offering amount: 279910 USD. Reported amount sold: 279910 USD.
- Aug. 27, 2025 · D · 0001062993-25-014970 · Source evidence
Reported offering amount: 243231 USD. Reported amount sold: 147846 USD.
- April 22, 2025 · D · 0001062993-25-007763 · Source evidence
Reported offering amount: 3756009 USD. Reported amount sold: 1627604 USD.
- Jan. 22, 2025 · D · 0001062993-25-001002 · Source evidence
Reported offering amount: 434512 USD. Reported amount sold: 434512 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “NurExone Biologic Inc. research brief,” CIK 1995074, retrieved Nov. 19, 2026, 12:01 a.m.. Cite the specific accessions used. No amounts have been summed.